Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits. The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. 

The global CNS biomarker market was estimated at $1.7 billion in 2011 and nearly $2 billion in 2012. The market is projected to reach $5.1 billion by the end of the forecast period of 2012 to 2017, representing a compound annual growth rate (CAGR) of 20.7%.

GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of neurodegenerative and psychiatric disease. It infers that brain diseases are resulted from disruption of synaptic structure and function.

  • Neurogenesis and repair
  • Studies on neuronal circuits
  • GABA , 5HT receptors and its neuronal development
  • Synaptopathy in neurodegenerative diseases and ageing
  • Manipulation of ion channels by drugs

Related Conference of Molecular Neuropharmacology

Oct 31- Nov 02, 2016

5th International Conference on Forensic Research & Technology

San Francisco, California, USA
Nov 07-09, 2016

4th International Pharma & Clinical Pharmacy Congress

Las Vegas, Nevada, USA
Nov 07-09, 2016

4th International Pharma & Clinical Pharmacy Congress

Las Vegas, Nevada, USA
April 17-18, 2017

8th Global Pharmacovigilance & Drug Safety Summit

Bali, Indonesia
May 08-10, 2017

10th Asia-Pacific Pharma Congress

May 15-17, 2017

7th European Biosimilars Congress

Munich, Germany
July 10-12, 2017

9th Annual European Pharma Congress

Madrid, Spain
July 17-19, 2017

International Conference on Pigmentary Disorders

Melbourne, Australia
July 17-19, 2017

9th World Congress on BA/BE Studies and Biowaivers

Melbourne, Australia
July 24-26, 2017

8th World Congress on Pharmacology and Toxicology

Melbourne, Australia
July 31-Aug 02, 2017

7th Global Experts Meeting on Neuropharmacology

Milan, Italy
August 03-04, 2017

4th International Conference and Exhibition on Pain Medicine

San Francisco, USA
August 07-09, 2017

9th World Congress on Pharmacology

Paris, France
August 17-18, 2017

11th Annual Global Pharma Summit

San Francisco, USA
April 27-28, 2017

5th International Pharmacy Conference

Las Vegas, USA
Aug 21-22, 2017

Global Summit on Emerging Orphan Drugs and  Drug Abuse

San Francisco, USA
September 11-13, 2017

World Congress on Biotherapeutics

Dallas, USA
September 14-16, 2017

Immunology World

Amsterdam, Netherlands
September 18-19, 2017

International Conference on Next Generation Nanotechnology

Jackson Ville, USA
Sep 25-27, 2017

10th Pharmacovigilance Congress

Jackson Ville, USA
Sep 25-27, 2017

8th Annual Pharmaceutical Analysis Congress

Vienna, Austria
Sep 25-27, 2017

12th Annual Pharma Middle East Congress

Dubai, UAE
October 16-18, 2017

World Congress on Natural Products Chemistry and Research

Budapest, Hungary
October 19-21, 2017

9th Annual Congress on Drug Formulation & Drug Design

Seoul, South Korea
October 23-25, 2017

International Conference on Biotech Pharmaceuticals

Paris, France
September 11-13, 2017

4th International Conference on Clinical Trials

San Antonio, USA

Molecular Neuropharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in